Viral respiratory infections are a leading cause of hospitalizations and long-term medical complications in children throughout the world. These infections place infants and children at higher risk of developing wheezing and asthma later in life. When viral infections occur early in life, they may cause lung damage. Respiratory infections are a leading cause of hospitalizations in the United States and a major cause of mortality among children under age five worldwide. Respiratory syncytial virus (RSV), influenza and COVID-19 are all conditions that increase mortality risk among children. As such, scientific research in preventing respiratory viruses is essential for improving long-term health among children.
I enjoy learning how infections have shaped our world and society, and how interventions like antibiotics and vaccines can prevent infections. I enjoy figuring out what is causing an infection and how best to treat it. These interests stem from my work in various global healthcare settings, which made me determined to prevent respiratory viruses and other infections in children and infants.
One of my research interests involves vaccinating pregnant women to prevent their infants from contracting infectious diseases. In particular, my research aims to prevent respiratory viruses by focusing on maternal vaccination. I hope to help infants and children avoid respiratory infections early in life.
In addition to my respiratory virus research, my colleagues and I are currently using our research experience and knowledge of respiratory viruses to study COVID-19 infections.
For my role in teaching information about infectious diseases, I was awarded the Optime Magistrum Award (Most Excellent Teacher) in 2017 and 2019 at the University of Cincinnati College of Medicine. This award recognized my work in teaching medical students about preventing infections using vaccines. I was also awarded a Fogarty International Clinical Research Fellowship from the National Institutes of Health in 2009. During this fellowship, I studied the etiology and seasonal factors of viral respiratory conditions in Honduran children under five years of age. In 2011, I was granted the Pediatric Infectious Diseases Society Blue Ribbon Research award for maternal vaccine research in Bangladesh.
I continued influenza vaccine research in 2011 with the support of the Procter Scholars award and a K12 Child Health Research Career Development Award (CHRCDA) from the National Institutes of Health. My research has been published in respected journals, such as the Journal of Infectious Diseases, The Lancet Global Health, Influenza and Other Respiratory Viruses, Journal of the Pediatric Infectious Diseases Society, Pediatric Research and Vaccine.
MD: University of Cincinnati, Cincinnati, OH, 2003.
Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2006.
Chief Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2007.
Fellowship: Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2011.
MPH: Public Health, University of Cincinnati, Cincinnati, OH, 2011.
Certification: Pediatrics, 2006; Pediatric Infectious Diseases, 2013.
Global health; influenza; prevention of infant infection with maternal immunization
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trial. Vaccine. 2026; 72:128072.
Influenza Antiviral Use in Hospitalized Children Before and During the COVID-19 Pandemic. Pediatrics. 2026.
P-2170. Detection of Human Adenovirus with and without Co-detection of Other Respiratory Viruses Among Children with Acute Respiratory Illnesses. Open Forum Infectious Diseases. 2026; 13(Supplement_1):ofaf695.2333.
P-1651. Long-term Outcomes Compared between Children Hospitalized for Multisystem Inflammatory Syndrome in Children (MIS-C) and Children Hospitalized for Acute COVID-19, New Vaccine Surveillance Network (NVSN) — United States, 2020-2022. Open Forum Infectious Diseases. 2026; 13(Supplement_1):ofaf695.1826.
226. Effectiveness of Maternal Influenza Vaccination during Pregnancy against Medically Attended Influenza among Infants <6 Months of Age, New Vaccine Surveillance Network (NVSN), 2016-2017 through 2024-2025 Influenza Seasons. Open Forum Infectious Diseases. 2026; 13(Supplement_1):ofaf695.009.
Influenza Vaccine Effectiveness Among Children With and Without Underlying Conditions. Pediatrics. 2026.
Socioeconomic and Psychosocial Needs in Pediatric Infectious Diseases Outpatient Settings. Clinical Pediatrics. 2026; 99228251411610.
Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2 Years Hospitalized With RSV. Pediatrics. 2026.
Adenovirus Types in US Children Hospitalized or Seen in the Emergency Department With Acute Respiratory Illness, 2016-2019. Open Forum Infectious Diseases. 2025; 12(12):ofaf692.
Enterohepatic Non-H. pylori Helicobacter Infection in a Patient With X-Linked Agammaglobulinemia. Pediatric Dermatology. 2025.
Elizabeth P. Schlaudecker, MD, MPH, Mary Allen Staat, MD, MPH11/18/2024
Elizabeth P. Schlaudecker, MD, MPH2/20/2024
Elizabeth P. Schlaudecker, MD, MPH2/3/2022
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey